Heart failure in North America

John E A Blair1, Mark Huffman, Sanjiv J Shah

  • 1San Antonio Military Medical Center, San Antonio, TX, USA. Jblair1@gmail.com

Insights

Heart failure prevalence varies across North America due to economic, cultural, and risk factor differences. Understanding these disparities is key to improving heart failure prevention and treatment globally.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Heart failure (HF) is a significant global health concern impacting patients and healthcare systems.
  • North America exhibits considerable variation in HF epidemiology due to economic, genetic, cultural, and treatment trends.
  • Industrialized nations like the US and Canada face rising HF incidence linked to lifestyle changes and aging populations.

Purpose of the Study:

  • To analyze inter- and intra-continental disparities in heart failure (HF) across North America.
  • To explore the influence of economic development, demographics, and risk factors on HF prevalence and management.
  • To identify potential strategies for improved HF prevention and treatment based on regional differences.

Main Methods:

  • Comparative analysis of epidemiological data across the United States, Canada, and Mexico.
  • Examination of demographic trends, including urbanization and ethnic variations.
  • Review of risk factors, disease etiology (e.g., heart failure with preserved ejection fraction), and management strategies.

Main Results:

  • Significant differences exist in HF etiology, severity, and management between industrialized (US, Canada) and transitioning economies (Mexico).
  • Heart failure with preserved ejection fraction constitutes about half of North American HF admissions, with notable demographic and etiological variations.
  • Ethnic disparities within the US and Canada highlight evolving demographics and potential care inequities.

Conclusions:

  • Understanding North American HF differences is crucial for advancing the global understanding of the HF epidemic.
  • Addressing economic, demographic, and ethnic variations can inform tailored prevention and treatment strategies.
  • Varied approaches to managing the economic burden of HF necessitate further investigation for optimal healthcare system support.

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
329
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
305
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
894
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
865
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.5K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
963